Bonyf N.V (MLBON) | Financial Analysis & Statements
Bonyf N.V. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2021Income Metrics
Revenue
789.4K
Operating Income
789.4K
100.00%
Net Income
789.4K
100.00%
EPS (Diluted)
€1.34
Balance Sheet Metrics
Total Assets
1.7M
Total Liabilities
1.2M
Shareholders Equity
434.0K
Debt to Equity
2.87
Cash Flow Metrics
Operating Cash Flow
236.5K
Free Cash Flow
236.5K
Revenue & Profitability Trend
Quarter Income Flow Mar 31, 2021
Annual Income Flow
2024
Bonyf N.V Income Statement From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 281.5K | 309.4K | 277.4K | 2.4M | 3.2M |
| Cost of Goods Sold | 258.9K | 283.0K | 267.3K | 715.2K | 1.0M |
| Gross Profit | 22.6K | 26.4K | 10.0K | 1.7M | 2.2M |
| Gross Margin % | 8.0% | 8.5% | 3.6% | 69.9% | 67.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 573.5K | 591.7K |
| Other Operating Expenses | 3.1K | 10.6K | 221.5K | 68.9K | 105.4K |
| Total Operating Expenses | 3.1K | 10.6K | 221.5K | 642.4K | 697.2K |
| Operating Income | -34.7K | -39.9K | -317.5K | -48.8K | 226.0K |
| Operating Margin % | -12.3% | -12.9% | -114.5% | -2.1% | 7.1% |
| Non-Operating Items | |||||
| Interest Income | 980 | 0 | - | 0 | 0 |
| Interest Expense | 2.8K | 1.0M | 3.0M | 18.2K | 32.5K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -36.5K | -1.0M | -3.3M | -67.1K | 193.5K |
| Income Tax | - | - | - | 3.1K | 2.8K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 1.4% |
| Net Income | -36.5K | -1.0M | -3.3M | -70.2K | 190.7K |
| Net Margin % | -13.0% | -337.7% | -1,196.1% | -3.0% | 6.0% |
| Key Metrics | |||||
| EBITDA | -33.7K | -39.9K | -267.5K | 3.9K | 268.2K |
| EPS (Basic) | - | - | €-5.64 | €-0.12 | €0.32 |
| EPS (Diluted) | - | - | €-5.64 | €-0.12 | €0.32 |
| Basic Shares Outstanding | - | - | - | 588600 | 588600 |
| Diluted Shares Outstanding | - | - | - | 588600 | 588600 |
Income Statement Trend
Bonyf N.V Balance Sheet From 2019 to 2024
| Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 5.0K | 10.0K | 393 | 50.5K | 38.8K |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 64.2K | 35.0K | 129.8K | 134.4K | 114.2K |
| Inventory | 19.9K | 37.3K | 23.8K | 499.3K | 422.3K |
| Other Current Assets | - | - | - | 13.6K | 16.6K |
| Total Current Assets | 340.9K | 92.9K | 170.6K | 1.1M | 1.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | 15.2K | 16.8K |
| Goodwill | - | - | - | 78.1K | 90.6K |
| Intangible Assets | - | - | - | 78.1K | 90.6K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 3.0M | 3.0M | 4.0M | 302.7K | 350.6K |
| Total Assets | 3.3M | 3.1M | 4.2M | 1.4M | 1.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 311.7K | 299.6K | 364.7K | 228.4K | 242.4K |
| Short-term Debt | 36.0K | 75.0K | 0 | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 306.1K | 12.8K | 2.0K | - | - |
| Total Current Liabilities | 674.7K | 411.9K | 445.0K | 258.9K | 256.3K |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | 267.7K | 221.8K |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 21.8K | - | - | 573.0K | 563.1K |
| Total Non-Current Liabilities | 21.8K | 0 | 0 | 840.6K | 785.0K |
| Total Liabilities | 696.5K | 411.9K | 445.0K | 1.1M | 1.0M |
| Equity | |||||
| Common Stock | 7.1M | 7.1M | 7.1M | 293.5K | 289.5K |
| Retained Earnings | -4.4M | -4.4M | -3.3M | -13.5K | 55.9K |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.6M | 2.7M | 3.7M | 280.1K | 345.5K |
| Key Metrics | |||||
| Total Debt | 36.0K | 75.0K | 0 | 267.7K | 221.8K |
| Working Capital | -333.8K | -319.1K | -274.4K | 818.0K | 779.8K |
Balance Sheet Composition
Bonyf N.V Cash Flow Statement From 2020 to 2020
| Metric | 2020 |
|---|---|
| Operating Activities | |
| Net Income | - |
| Depreciation & Amortization | - |
| Stock-Based Compensation | - |
| Working Capital Changes | 0 |
| Operating Cash Flow | 57.0M |
| Investing Activities | |
| Capital Expenditures | - |
| Acquisitions | - |
| Investment Purchases | - |
| Investment Sales | - |
| Investing Cash Flow | - |
| Financing Activities | |
| Share Repurchases | - |
| Dividends Paid | - |
| Debt Issuance | - |
| Debt Repayment | - |
| Financing Cash Flow | - |
| Free Cash Flow | 57.0M |
| Net Change in Cash | 57.0M |
Cash Flow Trend
Bonyf N.V Key Financial Ratios
Valuation Ratios
Price to Book
5.72
Price to Sales
8.03
Profitability Ratios
Profit Margin
8.02%
Operating Margin
-12.90%
Return on Equity
-32.61%
Return on Assets
-0.69%
Financial Health
Current Ratio
0.23
Debt to Equity
0.00
Beta
-0.03
Per Share Data
EPS (TTM)
€-1.77
Book Value per Share
€0.74
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MLBON | 2.5M | - | 5.72 | -32.61% | 8.02% | 0.00 |
| Sartorius Stedim | 15.8B | 59.45 | 3.86 | 6.59% | 8.98% | 63.11 |
| Crossject S.A | 105.6M | - | - | 212.74% | 0.00% | -4.61 |
| Visiomed Group SA | 52.8M | 59.67 | - | 3.64% | 45.95% | 0.32 |
| Spineway S.A | 5.8M | 16.20 | 0.25 | -9.46% | -17.47% | 6.63 |
Financial data is updated regularly. All figures are in the company's reporting currency.